In the bustling heart of Miami, amidst the buzz of the Benzinga Cannabis and Psychedelics Capital Conference, a pivotal conversation ignited a partnership destined to revolutionize the world of wellness. Jeff Stevens, CEO of Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9), and Harrison Aaron of cannabis investment firm Gotham Green were about to embark on a journey fueled by the potential of the Amanita Muscaria mushroom.

What's Psyched Wellness

Psyched Wellness is a pioneer in the field of life sciences. Its focus is the production and distribution of wellness products derived from the Amanita Muscaria mushroom.

The company has developed its proprietary extract, AME-1, which, after years of thorough studies and stringent US GRAS certification, has proven safe for human consumption.

A Multi-Million Dollar Conversation

The meeting between Stevens and Aaron led to a binding agreement between Psyched Wellness and Gotham Green Fund III. This collaboration paves …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.